LISA DIGLIO: Open Payments
NPI 1275527061 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,708 in 86 payments from 18 companies in 2025. Trend: 2023 $1,193 · 2024 $1,058 · 2025 $1,708
Food & beverage: $1,708
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $263 |
| ABBVIE INC. | 14 | $202 |
| AstraZeneca Pharmaceuticals LP | 9 | $184 |
| Novo Nordisk Inc | 11 | $183 |
| GlaxoSmithKline, LLC. | 9 | $143 |
| Madrigal Pharmaceuticals | 4 | $137 |
| Lilly USA, LLC | 5 | $106 |
| Corcept Therapeutics | 4 | $89 |
| Exact Sciences Corporation | 5 | $79 |
| SHIELD THERAPEUTICS INC | 3 | $65 |
Products named: CAPLYTA, REZDIFFRA, TRELEGY ELLIPTA, AIRSUPRA, UBRELVY, MOUNJARO, Korlym, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
